metronidazole has been researched along with phenobarbital in 20 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 10 (50.00) | 18.7374 |
| 1990's | 1 (5.00) | 18.2507 |
| 2000's | 5 (25.00) | 29.6817 |
| 2010's | 4 (20.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Topliss, JG; Yoshida, F | 1 |
| Lombardo, F; Obach, RS; Waters, NJ | 1 |
| González-Díaz, H; Orallo, F; Quezada, E; Santana, L; Uriarte, E; Viña, D; Yáñez, M | 1 |
| Chupka, J; El-Kattan, A; Feng, B; Miller, HR; Obach, RS; Troutman, MD; Varma, MV | 1 |
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
| Choi, SS; Contrera, JF; Hastings, KL; Kruhlak, NL; Sancilio, LF; Weaver, JL; Willard, JM | 1 |
| Chang, G; El-Kattan, A; Miller, HR; Obach, RS; Rotter, C; Steyn, SJ; Troutman, MD; Varma, MV | 1 |
| Chen, M; Fang, H; Liu, Z; Shi, Q; Tong, W; Vijay, V | 1 |
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Dehne, M; el Abed, K; Hofmann, W; Kroh, U; Lennartz, H | 1 |
| Loft, S; Poulsen, HE | 1 |
| Haataja, H; Männistö, PT; Saijonmaa, O | 1 |
| Døssing, M; Jørgensen, BG; Loft, S; Petersen, KT; Poulsen, HE; Sonne, J | 1 |
| Hospador, MA; Manthei, RW | 1 |
| Alterthum, K; Bauer, P; Stünkel, S; Windorfer, A | 1 |
| Agosin, M | 1 |
| Gupte, S | 1 |
| Gibson, M; Mead, PB; Schentag, JJ; Ziemniak, JA | 1 |
| Ben Rachid, MS; Bouhaouala, MH; Ghedas, K; Kchouk, M; Khaldi, M; Larnaout, A; Touibi, S | 1 |
1 review(s) available for metronidazole and phenobarbital
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
19 other study(ies) available for metronidazole and phenobarbital
| Article | Year |
|---|---|
QSAR model for drug human oral bioavailability.
Topics: Administration, Oral; Biological Availability; Humans; Models, Biological; Models, Molecular; Pharmaceutical Preparations; Pharmacokinetics; Structure-Activity Relationship | 2000 |
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding | 2008 |
Quantitative structure-activity relationship and complex network approach to monoamine oxidase A and B inhibitors.
Topics: Computational Biology; Drug Design; Humans; Isoenzymes; Molecular Structure; Monoamine Oxidase; Monoamine Oxidase Inhibitors; Quantitative Structure-Activity Relationship | 2008 |
Physicochemical determinants of human renal clearance.
Topics: Humans; Hydrogen Bonding; Hydrogen-Ion Concentration; Hydrophobic and Hydrophilic Interactions; Kidney; Metabolic Clearance Rate; Molecular Weight | 2009 |
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Development of a phospholipidosis database and predictive quantitative structure-activity relationship (QSAR) models.
Topics: | 2008 |
Physicochemical space for optimum oral bioavailability: contribution of human intestinal absorption and first-pass elimination.
Topics: Administration, Oral; Biological Availability; Humans; Intestinal Absorption; Pharmaceutical Preparations | 2010 |
FDA-approved drug labeling for the study of drug-induced liver injury.
Topics: Animals; Benchmarking; Biomarkers, Pharmacological; Chemical and Drug Induced Liver Injury; Drug Design; Drug Labeling; Drug-Related Side Effects and Adverse Reactions; Humans; Pharmaceutical Preparations; Reproducibility of Results; United States; United States Food and Drug Administration | 2011 |
IARC monographs on the evaluation of the carcinogenic risk of chemicals to man: some miscellaneous pharmaceutical substances.
Topics: Acriflavine; Animals; Anthralin; Aurothioglucose; Carcinogens; Chloroquine; Diazepam; Ethanolamines; Ethionamide; Female; Humans; Hycanthone; Male; Metronidazole; Neoplasms; Neoplasms, Experimental; Oxazepam; Oxymetholone; Oxyphenbutazone; Oxyquinoline; Phenacetin; Phenobarbital; Phenylbutazone; Phenytoin; Pregnancy; Pyrimethamine; Risk | 1977 |
[Dosage adjustment of drugs during continuous hemofiltration. Results and practical consequences of a prospective clinical study].
Topics: Adult; Aged; Cefotaxime; Ceftazidime; Digitoxin; Digoxin; Hemofiltration; Humans; Imipenem; Kidney Failure, Chronic; Metronidazole; Middle Aged; Netilmicin; Pharmaceutical Preparations; Phenobarbital; Phenytoin; Theophylline; Tobramycin; Vancomycin | 1989 |
Metabolism of metronidazole and antipyrine in isolated rat hepatocytes. Influence of sex and enzyme induction and inhibition.
Topics: Acetates; Animals; Antipyrine; Cytochrome P-450 Enzyme System; Drug Interactions; Enzyme Induction; Female; Glucuronates; Hydroxides; Isoenzymes; Kinetics; Liver; Male; Methylcholanthrene; Metronidazole; Phenobarbital; Rats; Rats, Inbred Strains; Sex Factors; Sulfates | 1989 |
Effect of enzyme induction and inhibition on the fate of metronidazole and tinidazole in the rat.
Topics: Animals; Bile; Biotransformation; Chromatography, High Pressure Liquid; Cimetidine; Enzyme Induction; Enzyme Inhibitors; Male; Metronidazole; Nitroimidazoles; Phenobarbital; Rats; Rats, Inbred Strains; Tinidazole | 1987 |
Inhibition and induction of metronidazole and antipyrine metabolism.
Topics: Adult; Antipyrine; Cimetidine; Drug Interactions; Female; Humans; Hydroxylation; Kinetics; Male; Metronidazole; Phenobarbital | 1987 |
Influence of age and diet on the induction of hexobarbital-metabolizing enzymes in the mouse.
Topics: Age Factors; Animals; Animals, Newborn; Antipyrine; Benzopyrenes; Biotransformation; Caseins; Diet; Enzyme Induction; Hexobarbital; Histamine H1 Antagonists; Liver; Male; Metronidazole; Mice; Microsomes; Oils; Phenobarbital; Piperazines; Sleep; Starvation; Zea mays | 1968 |
[Effects of drug interaction in infancy (author's transl)].
Topics: Carbamazepine; Child; Chloramphenicol; Clonazepam; Dexamethasone; Drug Interactions; Humans; Isoniazid; Metronidazole; Phenobarbital; Phenytoin; Sulfonamides; Valproic Acid | 1980 |
The aerobic metabolism of metronidazole by Trypanosoma cruzi epimastigotes.
Topics: Aerobiosis; Animals; Metronidazole; Metyrapone; Phenobarbital; Proadifen; Species Specificity; Time Factors; Trypanosoma cruzi | 1983 |
Phenobarbital and metabolism of metronidazole.
Topics: Child; Half-Life; Humans; Metronidazole; Phenobarbital; Stimulation, Chemical | 1983 |
Possible alteration of metronidazole metabolism by phenobarbital.
Topics: Female; Humans; Metronidazole; Phenobarbital | 1982 |
[Amebic brain abscess. Apropos of a case].
Topics: Adult; Animals; Brain Abscess; Combined Modality Therapy; Entamoeba histolytica; Entamoebiasis; Humans; Male; Metronidazole; Phenobarbital; Tomography, X-Ray Computed | 1993 |